🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

“In patients with suspected oral lesions in the presence of oral mucosal cGVHD, an intervention for oral cGVHD may be considered to differentiate the chronic disease from oral cancer.” Read more: link.springer.com/article/10.100…

“Toothbrushing and proficient interproximal cleaning should not be discouraged during HCT.” Read more: link.springer.com/article/10.100…

“The correlation between salivary gland hypofunction and xerostomia is poor. Therefore, not all patients with xerostomia demonstrate the clinical signs and symptoms of salivary gland hypofunction and vice versa.” Read more: link.springer.com/article/10.100…

“The information presented in this CPS offers clinicians convenient access to the dosages and regimens of different interventions for managing salivary gland hypofunction or xerostomia.” Read more: link.springer.com/article/10.100…

“Proper description of the oral adverse effects will help with the diagnosis and direct the treatment accordingly. Clinicians are advised to be aware that some oral adverse effects may have symptoms without apparent abnormal findings.” Read more: link.springer.com/article/10.100…

Have you #sharedit? MASCC/ISOO Clinical Practice Statement: Adjuvant bone-modifying agents in primary breast cancer patients-prevention of medication-related osteonecrosis of the jaw, from Supportive Care in Cancer is free to read link.springer.com/article/10.100…

Have you #sharedit? MASCC/ISOO Clinical Practice Statement: Management of oral manifestations of chronic graft-versus-host-disease, from Supportive Care in Cancer is free to read link.springer.com/article/10.100…

Have you #sharedit? MASCC/ISOO Clinical Practice Statement: The risk of secondary oral cancer following hematopoietic cell transplantation, from Supportive Care in Cancer is free to read link.springer.com/article/10.100…

Have you #sharedit? MASCC/ISOO clinical practice statement: Current understanding on controversies in basic oral care in hemato-oncology and hematopoietic cell transplantation, from Supportive Care in Cancer is free to read link.springer.com/article/10.100…

Have you #sharedit? MASCC/ISOO Clinical Practice Statement: Clinical assessment of salivary gland hypofunction and xerostomia in cancer patients, from Supportive Care in Cancer is free to read link.springer.com/article/10.100…

Join us for the upcoming Oral Care Study Group Case Report Session on Monday, Dec. 16, 2024. Please register to join us via Zoom: lnkd.in/dScGZXeG Save the date!

Oral potentially malignant disorders (OPMDs) such as oral leukoplakia, oral erythroplakia, and oral submucous fibrosis have varying but significant risks of progressing to oral cancer. ja.ma/4fYEV3d

ISOO Members! Join the Oral Care Study Group Webinar Series for expert discussions in oral oncology. Next session: March 21, 2025 – Therapies for Immune-Mediated Oral Toxicities Special thanks to Drs. Sharon Elad & David Dean, UR Medicine & @MASCC_ISOO for organizing!

Join us for the next Oral Care Study Group presentation: March 21, 2025 Topic: Therapies for Immune-Mediated Oral Toxicities Presenter: Dr. Nathaniel Treister Register: urmc.zoom.us/webinar/regist…

The early bird registration deadline is coming up soon! Register by April 23, 2025 to take advantage of the reduced price for #MASCC25 We're looking forward to an exciting scientific program, as well a plenty of social and networking opportunities. mascc.org/annualmeeting2…

The ISOO-MASCC-ASCO group just published a JADA article on osteoradionecrosis prevention and management, highlighting key takeaways for the dental team. Thanks to all involved—check it out for the latest on ORN! jada.ada.org/article/S0002-…

ISOO leadership at the 2025 AAOM/EAOM Meeting in Vegas 🇺🇸 📸 ISOO President Dr. Noam Yarom, Past ISOO President Dr. Eduardo Fregnani & Past AAOM President Dr. Ken Ikeda — united in advancing oral supportive care.

Excited to share that the Oral Care Study Group will join the Speed Mentoring Event at #MASCC2025 in Seattle! 📅 June 27 | 🕜 1:30–4:30 PM 📍 Westin Hotel – Fifth Ave Room Dr. David Dean will mentor 1:30–2:30 PM. Stay tuned for registration info! #ISOO #MASCC2025

The best part of the 2025 MASCC/ISOO Annual Meeting? The people. Grateful to connect here in Seattle with colleagues who share our passion for oral oncology and supportive care. #MASCC2025 #ISOO #Seattle #OralOncology #SupportiveCare

Huge congratulations to our very own Dr. Deborah Saunders, winner of the 2025 DSA Award at MASCC/ISOO! A global leader in oral oncology, known for her work on MRONJ and clinical guidelines. We’re so proud! #MASCC2025 #ISOO #DSAAward #MRONJ #SupportiveCare